Harvest Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.8M Buy
+14,702
New +$1.79M 1.02% 38
2025
Q2
$1.56M Sell
14,032
-3,600
-20% -$383K 1% 40
2025
Q1
$1.98M Sell
17,632
-199
-1% -$20.5K 1.43% 17
2024
Q4
$1.65M Sell
17,831
-285
-2% -$25.7K 1.14% 30
2024
Q3
$1.52M Sell
18,116
-100
-0.5% -$7.63K 1.03% 41
2024
Q2
$1.25M Buy
18,216
+243
+1% +$16.2K 0.92% 44
2024
Q1
$1.32M Buy
17,973
+1,245
+7% +$95.7K 0.98% 44
2023
Q4
$1.36M Sell
16,728
-183
-1% -$14.2K 1.09% 36
2023
Q3
$1.27M Buy
16,911
+16
+0.1% +$1.23K 1.14% 35
2023
Q2
$1.3M Sell
16,895
-145
-0.9% -$11.6K 1.12% 37
2023
Q1
$1.41M Sell
17,040
-386
-2% -$32K 1.26% 27
2022
Q4
$1.5M Buy
+17,426
New +$1.38M 1.41% 20

Other funds holding GILD

Harvest Investment Advisors's GILD Position: Q4 2025 in Review

Harvest Investment Advisors opened a new position in Gilead Sciences (GILD) in Q4 2025: 14,702 shares worth $1.8M. The stake represents 1.02% of the portfolio and ranks #38 among its holdings. This is a return to the name: Harvest Investment Advisors previously reported a position in GILD as recently as Q2 2025.

Harvest Investment Advisors first reported a position in GILD in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.98M in Q1 2025. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Harvest Investment Advisors held 14,702 shares of Gilead Sciences worth $1.8M as of Q4 2025.
  • Gilead Sciences was a new Harvest Investment Advisors position in Q4 2025.
  • Gilead Sciences made up 1.02% of Harvest Investment Advisors's portfolio in Q4 2025, its #38 holding.
  • Harvest Investment Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 12 quarters since.
  • Harvest Investment Advisors's Gilead Sciences position peaked at $1.98M in Q1 2025.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Harvest Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.